Comparison of the GMA-TULIP and I-gel Laryngeal Mask for Airway Management in General Anaesthesia: a Randomized Controlled Trial
Launched by QILU HOSPITAL OF SHANDONG UNIVERSITY · Jun 5, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the GMA-TULIP laryngeal mask, a device used to help patients breathe during trauma surgery while they are under general anesthesia. The researchers want to find out if the GMA-TULIP fits better and works more effectively than another commonly used device called the i-gel laryngeal mask. They will look at how well the GMA-TULIP works in patients lying on their backs for surgery and will gather feedback from participants about their experience right after anesthesia and then again one hour and 24 hours later.
To be eligible for this study, you need to be between 18 and 70 years old and scheduled for trauma surgery in a supine position (lying on your back) under general anesthesia. You should also have a body mass index (BMI) between 18 and 35 and be in good health according to the American Society of Anesthesiologists grading. However, if you have a history of difficult airways or certain medical conditions, you may not be able to participate. If you join, you’ll be helping researchers learn more about airway management during surgery, which could improve safety and comfort for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years old ≤ age ≤ 70 years old. Patients undergoing trauma surgery in a supine position under general anesthesia.
- • 18 kg/m2 ≤ BMI ≤ 35 kg/m2. American Society of Anesthesiologists (ASA) grades I-III. Can understand the research process and the use of pain scales. Clear understanding and voluntary participation in the study, signing of informed consent form.
- Exclusion Criteria:
- • Patients with known or predicted difficult airways. High risk of reflux or aspiration (e.g., gastroesophageal reflux disease patients).
- • Individuals with active upper respiratory tract infections. Cervical related diseases or surgical history. Preoperative sore throat or previous sore throat or hoarseness. Patients with oral and maxillofacial trauma or fractures. Other reasons why researchers believe it is not appropriate to participate in the experiment.
About Qilu Hospital Of Shandong University
Qilu Hospital of Shandong University is a leading medical institution dedicated to advancing healthcare through innovative clinical research and patient-centered care. Affiliated with Shandong University, the hospital integrates clinical practice with education and research, fostering an environment that promotes scientific discovery and the development of new therapies. With a commitment to high standards of clinical excellence and ethical research practices, Qilu Hospital plays a pivotal role in enhancing patient outcomes and contributing to the global medical community through a diverse range of clinical trials and studies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jinan,, Shandong, China
Patients applied
Trial Officials
Shaozhong Yang, Doctor
Study Chair
Qilu Hospital of Shandong University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported